Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Aug 15.
Published in final edited form as: Acta Biomater. 2026 Jun 4;218:338–349. doi: 10.1016/j.actbio.2026.06.009

A microgel bone marrow model of mesenchymal stromal cell paracrine signaling supporting hematopoietic stem cell retention

Gunnar B Thompson a, Kaila M Kuo b, Andrés J García e,f, Brendan AC Harley a,c,d,*
PMCID: PMC13474313  NIHMSID: NIHMS2202349  PMID: 42248284

Abstract

Hematopoietic stem cells (HSCs) housed within the bone marrow give rise to the full complement of blood and immune cells. Methods to expand HSCs ex vivo have traditionally relied on two-dimensional or liquid culture, but hydrogel approaches have been hypothesized to provide three-dimensional bone marrow-associated biophysical and biomolecular signals that may improve HSC expansion and maintenance ex vivo. Here, we describe a granular biomaterial approach to create a multicellular platform for HSC culture. By seeding HSCs amongst mesenchymal stromal cell (MSC)-laden hydrogel microspheres (microgels), we establish paracrine-mediated interactions between HSCs and hydrogel encapsulated MSCs. We provide support for the importance of microgel encapsulation for the emergence of niche-favorable MSC transcriptional profiles. We identify a common cell culture media strategy that accommodates MSC activity while avoiding the use of serum that typically induces differentiation of HSCs. We observe an MSC-density-dependent increase in maintenance of long-term repopulating HSCs in granular co-culture, and we identify significant depletion of long-term repopulating HSCs when both HSCs and MSCs are interstitially seeded in the granular matrix. Together, these findings establish a granular hydrogel co-culture model to examine the influence of MSC-HSC interactions on maintenance and expansion of HSCs in a defined three-dimensional engineered tissue.

Statement of Significance: Hematopoietic stem cells (HSCs) give rise to the entire blood and immune systems and are clinically relevant in the treatment of hematologic disorders. These stem cells reside primarily within bone marrow, the heterogeneity of which is difficult to capture without advances in tissue modeling approaches. HSCs are supported by a plethora of colocalized “niche” cells, including mesenchymal stromal cells (MSCs). In vitro culture of HSCs has primarily used 2D substrates, large (bulk) hydrogels, or scaffolds. This manuscript reports the use of gelatin-maleimide microgels to create a granular hydrogel co-culture to regulate multicellular interactions between HSCs and marrow-derived MSCs. This work contrasts with most granular hydrogel studies, which seed cells only within the interstitial space between particles. We show that encapsulation of MSCs within gelatin microgels forms a mosaic culture that enhances maintenance of co-cultured hematopoietic stem cells, forming a prototypical granular model of bone marrow paracrine signaling.

Keywords: Microgel, Hematopoietic stem cell, Gelatin, Bone marrow, Mesenchymal stromal cell

1. Introduction

Hematopoietic stem cells (HSCs) are the apical cells that sustain the entire hematopoietic system by giving rise to mature, functional blood and immune cells (red blood cells, platelets, granulocytes, lymphoid cells, etc.) through hematopoiesis [1]. These cells primarily reside within the bone marrow of adults in both humans and mice, though HSCs regularly mobilize, trafficking in and out of the bone marrow in small numbers [2]. Hematopoiesis is the differentiation process by which a small number of HSCs that possess multipotency and self-renewal capacity undergo cell division to produce cell populations of progressively reduced stemness to fulfill specific functions such as oxygen transport, fighting infection, and blood clotting. Life-threatening disorders such as leukemia, lymphoma, and sickle cell disease involve dysfunction in the HSC pool [3].

HSC transplants have been administered as a curative therapy for a range of hematopoietic pathologies, but obstacles in donor matching and delivering a sufficient cell dose still limit their application and success. Prior to an allogeneic transplant, the patient must match with a donor, and this is far from guaranteed. In the United States, a patient who requires a transplant has up to an 88% chance of matching if they possess European ancestry, and as low as a 22% chance of matching if the individual is of African descent [4]. Additionally, engraftment success is correlated with the number of total cells [5] and with the number of CD34+ (clinical marker for human HSCs) cells delivered [6], and it is not always possible to obtain a sufficient number of cells from the donor. In lieu of an adult donor, it is possible to transplant HSCs from a cord blood unit to restore healthy hematopoiesis in a patient [7,8]. A benefit to this option is that cord blood transplant presents a lower risk of graft vs. host disease and has less stringent immune matching requirements; however, cord blood units are a less preferred source because they contain less HSCs and present an engraftment failure risk. It has been proposed that methods to expand donor HSCs ex vivo could ameliorate limitations regarding the deliverable cell dosage in HSC transplant [8,9]. Notably, this could also make cord blood a more viable source of HSCs. Because of the reduced immune matching requirements, cord blood expansion may have an extraordinary impact among demographics that historically suffer to find a donor in the United States.

Efforts to expand HSCs often take into account the bone marrow microenvironment, or niche, which provides the combination of mechanical, biochemical, and metabolic cues that regulate hematopoiesis [10,11]. Niche-associated cues include gradations in stiffness from the endosteum (inner bone surface) to the bone marrow center [12,13], gradations in oxygen tension from arteriolar to sinusoidal structures [14], as well as complex paracrine cell signaling originating from other niche cells [10]. Many niche cells have been implicated in regulation of hematopoiesis; however, mesenchymal stromal cells (sometimes called mesenchymal stem cells; MSCs) have been observed to provide many of the most critical signals necessary for maintenance of healthy hematopoiesis. Specific subtypes, including Nestin+ [15], Lepr+ [16], CXCL12-abundant reticular [17], and Ng2+ MSCs [18] have been implicated as critical mesenchymal niche cells subtypes (though significant overlap has been noted [10]). These niche cells regulate HSCs through the production of stem cell factor, CXCL12, pleiotrophin, and several other cytokines which are potent effectors of HSC maintenance and retention within the bone marrow.

Researchers have traditionally relied upon animal models that allow for tissue-specific and temporally modulated gene deletion to establish the role of signaling molecules and their cells of origin in HSC regulation. Efforts to expand HSCs have primarily utilized 2D culture methods, and most have aimed to grow HSCs in a medium supplemented with factors including stem cell factor [19,20], thrombopoietin [21], Flt3 ligand [22,23], IL-3 and IL-11 [22], or IL-6 [24], which promote stemness and proliferation in vivo. These approaches have also included the use of adipose-derived stem cells (ASCs) or MSCs as feeder layers for expansion of (cord-blood derived) HSCs [25,26]; however in some cases the use of a microporous membrane to separate HSCs from MSCs/ASCs was necessary to increase proliferation and self-renewal [27]. Inspired by the bone marrow niche, efforts have attempted to recapitulate the mechanical and biochemical makeup of the bone marrow using biomaterial systems. Biomaterial approaches, summarized thoroughly elsewhere [28–30], have ranged from marrow-inspired functionalization of polydimethylsiloxane and polyethylene glycol microwells [31,32] to collagen-coated carboxymethylcellulose [33] or fibronectin-coated polycaprolactone scaffolds [34] that present a 3D macroporous structure. Our lab has previously described the use of gelatin methacrylamide (GelMA) hydrogels that mimic the range of properties present in the bone marrow [35] to study the effect of co-culture of HSCs with MSCs or endothelial cells [12,36]. Coupled with characterization of diffusive biotransport [37], these approaches provide an avenue to define the relative contribution of paracrine vs. autocrine feedback in a multicellular cohort on HSC fate [38,39]. We recently developed a maleimide-functionalized gelatin (GelMAL) [40] to enable rapid formation of hydrogel microparticles, or microgels, that enables encapsulation of cells within individual droplets [41]. Microgels present significantly reduced diffusive lengths compared to conventional bulk hydrogels and can be packed to form granular aggregates [42], suggesting avenues to support cell growth and cell-cell communication at scale. We have recently reported rheology-based methods to characterize the yield stress behavior of heterogeneous populations of microgels [43], suggesting routes for in situ characterization of an engineered granular bone marrow formed from HSC and MSC-associated microgels. Mixtures of multiple distinct cell-laden microgel populations, or the seeding of discrete cell types in the interstices between cell-laden microgels provides an avenue to present discrete microenvironments to distinct cell populations simultaneously. This strategy suggests ways to effectively shape paracrine interactions while also tuning or eliminating direct cell-cell contact between distinct cell populations.

Here, we build upon our previous work by investigating the importance of hydrogel morphology for the biological behavior of co-cultured MSCs and HSCs. We describe multiple approaches to microgel-based culture and examine the role of MSC-generated paracrine signals on HSC expansion using the well-established murine hematopoiesis model [35]. We benchmark cell activity within GelMAL microgels vs. bulk GelMAL hydrogels (macrogels). We then establish a 3D HSC-MSC microgel culture platform, reporting the effect of the mode of MSC encapsulation (inside vs. between microgels), the weight-percentage of the polymer, and the MSC:HSC ratio on HSC proliferation vs. maintenance. Together, these studies suggest granular assemblies of cell-laden microgels offer the opportunity to create mosaic models of MSC-HSC interactions in the bone marrow that leverage the increased diffusivity of microgel cultures along with the ability to spatially organize distinct cell populations in 3D culture via separate encapsulation in discrete microgels.

2. Materials and methods

2.1. Gelatin maleimide synthesis

GelMAL was synthesized as previously described [41]. Gelatin (Type A, Bloom 300, Sigma-Aldrich) was dissolved in 10 mL 2-(N-morpholino) ethanesulfonic acid (MES, 1 M, pH 6.0, Gold Biotechnology) and 8 mL dimethyl sulfoxide (VWR) with stirring in a 20 mL vial. After gelatin was fully dissolved, N-hydroxysuccinimide 3-maleimidopropionate (Tokyo Chemical Industry) was dissolved in 2 mL dimethyl sulfoxide and mixed with the gelatin solution. The resultant mixture was adjusted to pH 4.5 using hydrochloric acid and allowed to react for 24 hours at 40°C with stirring. The reaction products were dialyzed in water acidified to pH 3.25, frozen, and lyophilized to obtain a dry polymer. The degree of functionalization was measured with an 1H-NMR spectrometer (Varian Unity Inova 400, 400 MHz). Degree of functionalization was quantified relative to the phenylalanine peak of gelatin. GelMAL used in this study had a degree of functionalization of 0.56 (Fig S1).

2.2. Cell culture and medium formulation

C57BL/6 mouse MSCs were purchased from Cyagen (MUBMX-01001) and cultured using Oricell™ complete mesenchymal stem cell growth medium (Cyagen, MUXMX-90011). Cells were received at passage 6 and used at passage 8 – 9, in accordance with manufacturer’s guidelines.

HSC medium was formulated as previously reported [44]: 1X Penicillin-streptomycin-glutamine (Gibco), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer (HEPES, diluted from 1 M, Gibco), 1 mg/mL polyvinyl alcohol (PVA, 87 – 90% hydrolyzed, Sigma-Aldrich), 1X Insulin-transferrin-selenium-ethanolamine (Gibco), 100 ng/mL thrombopoietin (Peprotech), and 10 ng/mL stem cell factor in Ham’s F-12 Nutrient Mix (Gibco). An alternative HSC medium (HSC−PVA) was made using all of the listed components except for PVA (to accommodate MSC co-culture).

2.3. Microgel formation (acellular and cell-laden)

Microgels were formed using a flow-focusing microfluidic device as described previously [41,43,45]. Three solutions were initially made: 1) GelMAL hydrogel precursor in phosphate-buffered saline (PBS, Gibco), 2) 3% v/v SPAN80 (Sigma-Aldrich) in light mineral oil (Sigma-Aldrich), and 3) a 30 mg/mL solution of dithiothreitol (DTT) in PBS. A DTT-in-oil emulsion solution was then made: 4) by combining solutions (2) and (3) in a 3000:237 ratio of oil:DTT and emulsifying by sonication for 90 seconds. To form microgels, solutions (1), (2), and (4) were pumped through the microfluidic device at rates of 5 μL/min, 0.5 μL/min, and 30 μL/min respectively. Acellular microgels were collected in PBS, shaken on ice for 20 minutes to allow complete chemical crosslinking, and then washed with 0.1% Tween-20 (Sigma-Aldrich) in PBS to remove oil. Finally, microgels were washed three times in PBS and then measured, plated, or cultured. Microgels used in this study had a diameter of 198.5 ± 18.6 μm (Fig S2).

Cell-laden microgels were formed in a way similar to a previously described method [41]. Cells were first passaged using TryplE (Gibco) and quenched with MSC medium. Then, cells were washed twice with PBS to dilute serum proteins that would otherwise interfere with DTT/maleimide crosslinking. Cells were concentrated and suspended in hydrogel precursor at the desired concentration prior to microgel formation. Cell-laden microgels were collected in MSC medium, washed in 0.1% Tween-20-in-PBS, and then washed three times in the appropriate medium prior to plating or culture. 25 μL of microgels were formed with MSCs at a density of 4 × 106 cells/mL for MSC viability and gene expression experiments, per replicate. For co-culture experiments, MSC-laden microgels were formed with MSCs at a density of 2.4 × 105 – 3.2 × 105 cells/mL, corresponding to 6000 – 8000 MSCs per sample. To pack microgels, cell-laden microgels (as well as acellular microgels) were centrifuged at 300 rcf × 5 minutes and cultured in fibronectin-coated 24 well plates (#354411 Corning).

2.4. Viability and microgel imaging

Viability was assessed using a LIVE/DEAD cell imaging kit (R37601, Invitrogen). Cells were incubated with the live/dead stain mixture for 15 minutes prior to imaging. Images of cells cultured in 2D were acquired using an EVOS M5000 imaging system (Thermo Fisher). 2D cell viability and numbers were quantified using CellProfiler. Images of acellular and cell-laden microgels were acquired using a DMi8 Yokogawa spinning disk confocal microscope equipped with a Hamamatsu EM-CCD digital camera (Leica Microsystems, Inc., Deerfield, IL). For viability images, z-stacks were acquired with a step size of 7 μm and a total of 20 slices and compressed into maximum intensity projections. To estimate viability, the live and dead maximum intensity projections were binarized using the Otsu algorithm (this algorithm provided an accurate overlap with qualitatively observed staining). Cell viability was estimated as: AreaLive/(AreaLive + AreaDead). To visualize the initial condition of HSCs and MSCs together in a microgel culture, MSCs were labeled with Celltracker Green CMFDA (Invitrogen C7025) and encapsulated within microgels. HSCs were labeled with Celltracker Orange CMRA (Invitrogen C34551). All image handling and analyses were performed using ImageJ/FIJI. Acellular microgels were imaged for diameter measurements using brightfield and measured using ImageJ/FIJI.

2.5. Macrogel formation

GelMAL macrogels were formed by pipetting 20 μL of premixed MSC-laden hydrogel precursor into Teflon molds (dia. 5 mm) fixed to glass slides using a previously described approach [40]. Molds were transferred to a container with ice and covered for 20 minutes to allow for physical crosslinking. After 20 minutes, hydrogels were removed from the molds and transferred to 10 mg/mL DTT for chemical crosslinking in a 24 well plate. Macrogels were allowed to chemically crosslink for 20 minutes. Crosslinking solution was aspirated and replaced with PBS and allowed to wash for 5 minutes on a shaker at room temperature. Washes were repeated for a total of 4 washes before finally resuspending in MSC growth medium.

2.6. Gene expression

Gene expression was measured using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). RNA was isolated using the RNeasy mini kit (#74134, QIAGEN) and then reverse transcribed to cDNA using a QuantiTect Reverse Transcription Kit (#205313, QIAGEN) and MyCycler Thermal cycler (Bio-Rad Laboratories). Taqman Fast Advanced Master Mix and Taqman probes for genes of interest were purchased from Thermo Fisher (Table S1) [10,35, 46–51]. After preparing plates, qPCR was performed using a Real Time PCR QuantStudio 7 (Applied Biosystems). Data was processed using the ΔΔCT method. Gene expression was normalized to Gapdh expression for genes measured on each day. Two analyses were performed. First, the gene expression data at Days 4 and 7 were computed as fold-change vs. Day 1 gene expression. For example: Day 4 Col4a1 expression and Day 1 Col4a1 expression were normalized to Day 4 Gapdh expression and Day 1 Gapdh expression, respectively to obtain dCt for each. Then, ddCT was calculated as the difference between Day 4 Col4a1 and Day 1 Col4a1 and converted to fold-change [52,53]. In a second analysis, the expression of each gene (normalized against Gapdh for that condition and that day) was evaluated as the fold-change between microgel-encapsulated MSCs and macrogel-encapsulated MSCs.

2.7. 2D media screening

MSC viability assessment in response to distinct media formulations was performed in 2D culture, seeding 7350 MSCs per well in a 48 well plate (to approximate the cell/area of conventional T75 flask culture). Cells were grown in MSC growth medium, HSC medium, a 50:50 blend of MSC and HSC media, or HSC−PVA medium (HSC medium without PVA added). Cells were cultured for two days before evaluating viability.

2.8. 3D media screening

MSCs were encapsulated in GelMAL microgels and then seeded in a 24 well plate for culture for either 4 or 6 days. For 4-day media screening experiments, MSCs were cultured in either MSC medium or HSC−PVA medium. Medium was refreshed on day 2 and viability was evaluated after 4 days. Alternatively, MSCs were encapsulated within GelMAL microgels and cultured in MSC medium for 2 days before changing the medium to HSC−PVA medium for an additional 4 days. Medium was refreshed 2 days after this change, with MSC viability was evaluated 4 days after changing the medium.

2.9. Hematopoietic stem cell isolation and culture

All animal work was performed under approved animal welfare guidelines (Institutional Animal Care and Use Committee #23033, University of Illinois Urbana-Champaign). Hematopoietic stem cells (HSCs) were isolated as previously described from the tibiae and femora of female C57BL/6 mice aged 6 – 8 weeks (The Jackson Laboratory) [38, 41]. Bones were crushed to release bone marrow into an isolation buffer composed of 5% fetal bovine serum (FBS, R&D Systems) and 0.05 mM ethylenediaminetetraacetic acid (EDTA, Invitrogen) in PBS. Red blood cells were lysed using a 1X red blood cell lysis buffer (BioLegend). Samples were enriched for HSCs using the EasySep™ Mouse Hematopoietic Progenitor Cell Isolation Kit (#19856, Stemcell Technologies). Cells were then stained for a lineage (Lin) cocktail, Sca-1, c-Kit, and DAPI prior to cell sorting to isolate the Lineage−Sca-1+c-Kit+ (LSK) fraction of hematopoietic cells. Antibodies used for isolation staining are summarized in Table S2. Cells were sorted into HSC−PVA medium using a 5-laser Bigfoot Cell Sorter (Invitrogen). After collection, 6000 – 8000 LSKs were seeded over “pre-cultured” acellular or MSC-laden microgels.

2.10. Phenotypic analysis of hematopoietic cells after culture

HSC-MSC co-cultures were transferred to Eppendorf tubes and the hydrogel phase was degraded in 200 U/mL collagenase type IV (Worthington Biochemical Corporation). Cells were incubated with an Fc receptor blocker, followed by staining HSC markers using antibodies listed in Table S3. Cells were fixed in formalin prior to flow cytometry using a FACSymphony A1 system (BD Biosciences). Full-minus-one controls were used to set gates for analysis. Long-term repopulating HSCs (LTHSCs) were defined as CD150+CD48− LSKs, short-term repopulating HSCs (STHSCs) were defined as CD150−CD48− LSKs, and multipotent progenitors (MPPs) were defined as CD150+/− CD48+ LSKs [22,54]. Because MSCs were not separated from HSCs in this analysis, MSCs were cultured and subjected to flow cytometry in the absence of HSCs to confirm our ability to continue to use conventional markers to identify murine LSKs. MSCs were negative for lineage markers and c-Kit in flow cytometry experiments, indicating that for HSC analyses, any MSCs would appear within the general cell gate and Lin− gate, but not the LSK gate, and so would not affect the analysis of LSK status or any HSC-specific gates (Fig S3, Fig S4).

2.11. Statistics

Scatterplots and barplots report the mean ± standard error of the mean, unless otherwise noted. The Shapiro-Wilk test was used to test for normality prior to statistical analyses [55,56], and the Brown-Forsythe test was used to check equivalence of variance between two or more groups [57,58]. When normality and homoscedasticity were confirmed, conditions were compared using Student’s t-test, One-way ANOVA, or Two-way ANOVA, dependent upon number of groups and experimental design. Tukey’s Honest Significant Differences test was used to compare groups following ANOVA [59]. Welch’s t-test was used when normality was validated, but homoscedasticity was not between two groups [60]. The Kruskal-Wallis test was used to compare groups when normality or homoscedasticity were not valid assumptions [61], and groups were then compared using a Pairwise Wilcoxon Rank Sum test [62]. Plots were generated and statistical tests were performed in R statistical software.

3. Results

3.1. Mesenchymal stromal cell encapsulation inside of gelatin microgels alters patterns of gene expression

Because of potential exposure to increased shear during microgel encapsulation, we first assessed MSC viability and morphology within 4 wt% GelMAL microgels, the stiffness of which were estimated by bulk compression to be 12.1 ± 2.2 kPa, on the order of bone marrow (Fig S5) [63]. MSCs displayed 89.3% ± 0.5% viability and a rounded morphology immediately after encapsulation (Fig. 1A–B). By day 1 some MSCs had begun to spread, while by day 3 most MSCs displayed a spread morphology, increased localization toward the microgel surface, and increased density that suggested proliferation. Within 7 days of culture, MSCs fully colonized the surface of the microgels. While viability remained high throughout the 7-day culture, increased fractions of dead cells were observed by day 7 (cell viability: 83.0% ± 7.0%), and many of the dead cells were observed near the center of microgels (Fig S6).

Fig. 1.

Fig. 1.

A MSCs were encapsulated in 4 wt% GelMAL microgels and cultured for a period of 7 days to assess viability. Scale bar 200 μm. B Quantified viability shows that MSCs encapsulated within 4 wt% GelMAL microgels maintain high viability over a period of 7 days. C Patterns of gene expression for key remodeling and HSC-regulating genes at days 4 and 7. Data were first normalized to Gapdh on the same day, and then fold-change was calculated by comparing against the expression of the gene of interest at day 1. n = 3 independent replicates for each day. ^ indicates p < 0.1 vs. D1. * indicates p < 0.05 vs D1 (t-test).

We then investigated gene expression of MSCs encapsulated in microgels using a panel of marrow remodeling-associated genes (Mmp2, Mmp9, Mmp13, Timp1, Timp2, Timp3), matrix synthesis genes (Col1a1, Col4a1, Fn1), and HSC-supportive genes (Kitl, Cxcl12, Vcam1, Spp1, and Ptn). Gene expression data were collected from MSCs encapsulated in 4 wt% GelMAL hydrogels at 1, 4, and 7 days after encapsulation. Expression of remodeling-associated, extracellular matrix (ECM), and HSC-supportive genes trended upward over time for microgel-encapsulated MSCs with only a few exceptions (decreased expression of Mmp13, Spp1, and Timp1; Fig. 1C). Mmp2 and Mmp9, associated with ECM degradation, increased significantly by day 7, which likely facilitated the migration of MSCs to the periphery of microgels. The expression of several HSC-supportive genes, including Cxcl12, Kitl, and Ptn was consistent over time while Vcam1 expression increased slightly by day 7. The expression of Timp3 also increased by day 7, suggesting a slowdown in hydrogel matrix degradation.

We also compared viability and gene expression for MSCs encapsulated in microgels vs. macrogels (Fig. 2). Similarly to microgel-encapsulated MSCs, macrogel-encapsulated MSCs maintained high viability through day 7 of culture (Fig S7). At Day 1, we observed no differences between treatments. Over time, the expression of most genes by microgel-encapsulated MSCs eclipsed macrogel-encapsulated MSCs. By Day 7, the fold-difference between microgel- and macrogel-encapsulated MSCs had become statistically significant for all genes at the p < 0.05 level except Mmp13, Mmp2, Spp1, and Timp1. Of these, Mmp13, Mmp2, and Spp1 were significant at the p < 0.1 level. To support these findings, we evaluated the expression of several HSC-supportive proteins – CXCL12, SCF (Kitl), and PTN. PTN expression was undetectable for both microgel- and macrogel-encapsulated MSCs. Both CXCL12 and SCF expression were higher for microgel-encapsulated MSCs in agreement with gene expression results (Fig S8–S9). These data suggest that microgel encapsulation may profoundly improve the gene expression profile of 3D-encapsulated MSCs in the context of bone marrow remodeling and HSC maintenance.

Fig. 2.

Fig. 2.

Comparison of gene expression for microgel-encapsulated and macrogel-encapsulated MSCs. For each encapsulation condition and each timepoint, gene expression was normalized to Gapdh expression, by timepoint and condition. Fold-change was calculated between microgel-encapsulated MSCs and macrogel-encapsulated MSCs at each timepoint, for each gene. n = 3 independent replicates for each day, for each condition. ^ indicates p < 0.1. * indicates p < 0.05. ** indicates p < 0.01.

3.2. Media screening to identify appropriate conditions for hematopoietic and mesenchymal cell co-culture

Direct co-culture of HSCs and MSCs requires a single medium formulation to support both cells. We compared a defined HSC expansion medium, identified by Wilkinson et al. [21] and conventional MSC growth medium (that contains undefined factors and FBS). As HSC function is the primary focus of this work, we identified a medium formulation that would best accommodate HSCs in culture and would be tolerated by MSCs. MSC viability was defined after 2 days of culture in MSC medium, HSC medium, or a 50:50 blend of MSC and HSC media (Fig. 3A, Fig S10–11). MSC viability was prohibitively low in HSC medium. A 50:50 blend of MSC medium and HSC medium resulted in equivalent viability and increased proliferation, but the presence of FBS in the medium was undesirable for HSC culture. To better accommodate MSCs in an HSC medium that did not contain any MSC medium-associated serum, we cultured MSCs in the HSC medium containing all components except PVA (designated as HSC−PVA). MSC viability and proliferation in HSC−PVA medium were reduced relative to the MSC and 50:50 blend, but were far superior to the base HSC medium and the elimination of FBS that could induce differentiation in HSCs was preferred. As a result, HSC−PVA medium was selected for the rest of the MSC and HSC co-culture experiments.

Fig. 3.

Fig. 3.

A Images show live and dead cell populations for MSCs that were seeded in 2D and cultured in a variety of media. Scale bar 200 μm. B Experimental approach for the pre-culture of MSCs with MSC growth medium, followed by a switch to HSC−PVA medium. Figure created with BioRender. C Viability at the culture endpoint for MSCs encapsulated in 4 wt% GelMAL microgels. When cultured in MSC or HSC−PVA medium only, cells were cultured for 4 days. In the case of pre-culture, MSCs were cultured for a total of 6 days (2 days in MSC medium and 4 days in HSC−PVA medium). * indicates p < 0.05. D Representative image of MSCs after pre-culture in MSC medium and 4-day culture in HSC−PVA medium. Scale bar 200 μm.

We then evaluated MSC viability as a function of culture medium when encapsulated in 4 wt% GelMAL microgels for 4 days (the target culture duration for HSCs). As expected, the MSC medium accommodated high viability and growth; however, despite the high viability observed when MSCs were cultured in 2D in HSC−PVA medium alone, MSCs seeded in microgels fared poorly in HSC−PVA medium (Fig S12). To address this problem, we adopted a new experimental approach in which MSCs would be encapsulated and initially “pre-cultured” in MSC growth medium for two days with the goal to reduce damage from encapsulation, prior to a medium change to the HSC−PVA medium coinciding with introduction of HSCs for subsequent culture (Fig. 3B). When cultured in this manner, MSC viability improved, reaching 84.6% ± 5.5% at day 4 of HSC−PVA medium exposure, relative to the HSC−PVA medium with 22.4% ± 12.3% viability (Fig. 3C–D). We observed a roughly two-fold increase in DNA content between days 0 and 4 of HSC−PVA exposure, indicating that MSCs continued to proliferate after the medium change (Fig S13). We also measured the expression of Cxcl12 and Kitl (encoding SCF) with this medium change scheme and found that Cxcl12 expression was unchanged between days −1 and 4, while Kitl expression was elevated at day 4 (Fig S14). Finally, because PVA is considered a critical component of this HSC medium, we checked HSC viability when cultured in HSC medium with and without PVA, and found viability was maintained in both conditions (Fig S15). This approach was used for all subsequent HSC-MSC co-culture studies.

3.3. Phenotypic analysis of hematopoietic stem cells after co-culture with microgel-encapsulated mesenchymal stromal cells

MSCs were encapsulated in 4 wt% or 6 wt% GelMAL microgels and then seeded in 24-well plates at day −2 in conventional MSC medium, with acellular microgels fabricated as a control. 4 wt% is a continuation from previous work [41], and 6 wt% was chosen to present a matrix density similar to our previous work in GelMA that supported HSC maintenance [35]. The stiffness of 6 wt% GelMAL gels was measured to be 14.6 ± 1.1 kPa, which was not statistically different from the 4 wt% GelMAL gels. MSC viability was similarly high in 6 wt% GelMAL microgels at later time points compared to 4 wt% GelMAL microgels, though was initially lower after encapsulation (Fig S16). Medium was replaced with HSC−PVA, and HSCs were seeded interstitially into packed beds of MSC-laden or acellular granular gels at day 0 (Fig S17). Cultures were maintained for 4 days, then collected and processed for flow cytometry at day 4. The wt% of GelMAL had minimal impact on HSC phenotype: no effects were observed in the long-term repopulating HSC (LTHSC) or multipotent progenitor (MPP) populations. Co-culture with 6 wt% microgels led to an increase in the number of short-term repopulating HSCs (STHSCs) at Day 4 as a factor, but there were no statistical differences observed between individual conditions on the basis of wt % (Fig S18). The overall number of Lin− cells present at the end of culture was elevated at least in part due to MSCs appearing within the Lin− gate (Fig S3, Fig. 4A–B). Lin+ cell numbers were slightly elevated with MSC co-culture (Fig. 4C). The number of retained Lin−Sca-1+c-Kit+ cells (LSKs) increased with MSC co-culture (Fig. 4D). When LSKs were co-cultured with MSC-laden microgels, the number of LTHSCs was unaffected, while the number of STHSCs was reduced and the number of MPPs increased (Fig. 4E–G). Taken together, these data suggest that MSCs seeded within microgels increase the number of LSKs maintained and promote differentiation of STHSCs toward MPPs, inducing expansion of (more differentiated) Lin+ cells population. Interestingly, these downstream progeny changes occurred without losses in the LTHSC population, indicating distinct responses by distinct LSK subpopulations.

Fig. 4.

Fig. 4.

A HSCs were interstitially seeded in loosely packed beds of either acellular or MSC-laden 4 wt% GelMAL microgels and cultured for 4 days prior to flow cytometry analysis. MSCs were encapsulated within microgels. Figure created with BioRender. Plots present B Lin− cells normalized to the initial seeded number of cells, and C Lin+ cells normalized to the initial seeded number of cells. The HSC populations were analyzed and normalized against the initial number of ceded cells as follows: D LSKs, E LTHSCs, F STHSCs, G MPPs. * p < 0.05, ** p < 0.01.

3.4. Increasing the ratio of mesenchymal to hematopoietic cells enhances maintenance of long-term repopulating hematopoietic stem cells

Having seen an effect of MSC co-culture on HSC progeny, we next aimed to better define the relationship between the numbers of MSCs and HSCs in this system by increasing the MSC:HSC ratio and measuring HSC phenotype. We evaluated HSC monoculture (HSC cultures with acellular microgels), 1:1 HSC:MSC co-cultures, and 1:10 HSC:MSC co-cultures by again seeding MSCs at day −2 and adding HSCs at day 0 (Fig. 5A). The overall number of Lin− at day 4 were similar for niches containing 1X or 10X MSCs (Fig. 5B). Consistent with earlier results, the Lin+ fraction of hematopoietic cells increased with MSC density (Fig. 5C), whereas the number of LSKs decreased when the ratio of MSC: HSC was increased from 1:1 to 10:1 (Fig. 5D). Most notably, increasing the fraction of resident MSCs increased the size of the remaining LTHSC population (Fig. 5E), but at the expense of decreased numbers of downstream STHSCs and MPPs (Fig. 5F–G). These results suggest that LTHSCs are better maintained in the presence of MSC-laden 4 wt% GelMAL microgels.

Fig. 5.

Fig. 5.

A HSCs were interstitially seeded in loosely packed beds of either acellular or MSC-laden 4 wt% GelMAL microgels and cultured for 4 days prior to flow cytometry analysis. MSCs were encapsulated within microgels. Two ratios of MSC:HSC were tested – 1:1 and 10:1. Figure created with BioRender. Plots present B Lin− cells normalized to the initial seeded number of cells, and C Lin+ cells normalized to the initial seeded number of cells. The HSC populations were analyzed and normalized against the initial number of ceded cells as follows: D LSKs, E LTHSCs, F STHSCs, G MPPs. * p < 0.05.

3.5. Cell-cell contact in the granular model induced significant differentiation of hematopoietic stem cells

Microgel-based granular assemblies also allow for the facile incorporation of multiple cell populations interstitially. We briefly investigated the effect of seeding both HSC and MSC populations interstitially within the granular model, which allows for a greater degree of direct cell-cell contact between the HSCs and MSCs (Fig. 6A). While the Lin− population remained unchanged (Fig. 6B), a 4-fold to 5-fold expansion of Lin+ cells was observed (Fig. 6C), indicating significant hematopoietic differentiation and proliferation. While the number of LSKs was unchanged when moving MSCs from inside microgels to the interstices between microgels with the HSCs (Fig. 6D), we observed significant alterations in the composition of the LSK compartment. Notably, LTHSCs and STHSCs were nearly depleted (Fig. 6E–F). MPP numbers were unchanged in 1:1 HSC:MSC interstitial co-culture (Fig. 6G). Combined with the observation of Lin+ expansion, this result suggests a greater amount of differentiation within the MPP subpopulation when HSCs are co-cultured with MSCs interstitially in this granular material.

Fig. 6.

Fig. 6.

A HSCs were interstitially seeded in loosely packed beds of either acellular or MSC-laden 4 wt% GelMAL microgels and cultured for 4 days prior to flow cytometry analysis. MSCs were seeded interstitially in the bed of microgels. Figure created with BioRender. Plots present B Lin− cells normalized to the initial seeded number of cells, and C Lin+ cells normalized to the initial seeded number of cells. The HSC cell populations were analyzed and normalized against the initial number of ceded cells as follows: D LSKs, E LTHSCs, F STHSCs, G MPPs. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

4. Discussion

Hydrogels have enjoyed extensive use for cell culture due to their ability to recapitulate physiologically mimetic 2D and 3D microenvironments. Here, we investigated the effects of microgel encapsulation of MSCs upon MSC viability and gene expression. In previous work, we observed a roughly 10-fold increase in MSC number over 7 days of culture [41]. In the present study, viability was high at all measured timepoints, and MSCs encapsulated migrate to and colonize the surface of microgels within about 3 days. These observations are consistent with the behavior of human MSCs in degradable poly(ethylene glycol) microgels studied by Mora-Boza et al. [64]. The expression of many genes associated with ECM remodeling and HSC regulation was stable (Cxcl12, Kitl, Ptn) or increased (Vcam1, Mmp2, Mmp9) in culture out to 7 days. Cxcl12, Kitl, Ptn, and Vcam1 encode proteins that retain and promote the maintenance of HSCs within the bone marrow [16,65–70]. The upregulation of these factors highlights the utility of microgel encapsulation of MSCs to promote HSC stemness. Notably, Spp1 (which encodes the endosteal niche-associated factor osteopontin) is down-regulated over time, suggesting that these microgel-encapsulated MSCs more closely mimic the perivascular niche than the endosteal, or that microgel encapsulation is downregulating osteogenic potential [71]. Osteopontin has also been shown to enhance quiescence in HSCs [72]; future efforts may benefit from exogenous supplementation or engineering of an artificial niche that promotes Spp1 expression if proliferation is too high. The increase in Mmp2 and Mmp9 expression in microgels over time is consistent with the rapid migration of cells through the nanoporous hydrogel matrix, which necessitates metalloprotease-mediated breakdown. Interestingly, the mode of encapsulation was a significant determinant of gene expression. Microgel-encapsulated MSCs generally increased in their gene expression activity over time, while the expression in macrogel-encapsulated MSCs declined. The elevated Fn1 expression with microgel encapsulation relative to macrogel encapsulation suggests a more hematopoietic stem cell-supportive environment [73] as fibronectin has been shown to enhance the maintenance of immature HSCs by our lab [74] as well as by others [21,75]. Since the polymer itself was held constant in these cases, these data suggest the importance of hydrogel morphology – namely, that reduced diffusive lengths enhance transport of oxygen, nutrients, wastes, and paracrine signals throughout the culture.

We identified a medium formulation for effective co-culture of HSCs and MSCs that supported MSC activity and satisfied the primary objective of minimizing HSC exposure to serum-containing MSC media. Removal of PVA from the conventional HSC medium [21,44] facilitated MSC culture, albeit with reduced proliferation relative to conventional MSC medium. Even with the removal of PVA, MSCs encapsulated in microgels and cultured entirely in HSC−PVA medium suffered poor viability. Because we observed that in 2D culture the HSC−PVA medium can support MSCs, we hypothesize that microfluidic encapsulation presents stresses [76] to MSCs that are ameliorated by serum proteins or factors present in the MSC medium. This was further supported by the observation that HSC−PVA medium could support microgel-encapsulated MSCs, if MSCs were encapsulated and pre-cultured for 2 days in MSC growth medium. PVA was shown to support culture of several types of blood and immune cells by stabilizing recombinant cytokines [77], but unfortunately presented an incompatibility in our multicellular culture. It is possible that PVA interferes with MSC adhesion, resulting in cell death, as HSCs are generally considered non-adherent and tolerate PVA well; further experiments are necessary to elucidate the precise mechanism by which PVA is cytotoxic to MSCs.

When an equal number of microgel-encapsulated MSCs were cultured with HSCs, we observed an increase in overall hematopoietic progenitor (LSK) maintenance. Increasing the MSC:HSC ratio from 1:1 to 10:1 reduced the overall number of LSKs maintained. However, the most critical LTHSC population was variably affected by the presence of MSCs, with the weight of the combined evidence showing that microgel-encapsulated MSCs selectively preserve LTHSCs. STHSCs were consistently depleted by the inclusion of MSCs, with MPPs slightly increased (1:1 MSC:HSC), then depleted (1:10 HSC:MSC) in response to increasing fractions of microgel-encapsulated MSCs. The polymer wt% was expected to be a significant factor in the maintenance and differentiation patterns of HSCs in this experiment, as it was in previous bone marrow models from our lab [35]. In a previous study by Gilchrist et al., a stiffer (higher wt%) polymer was found to promote HSC maintenance when HSCs and MSCs were co-cultured in a 1:1 ratio in a GelMA hydrogel. We therefore expected a denser, stiffer matrix to enhance stemness in this co-culture study based on microgels; however, the polymer fraction only mildly increased STHSC retention and was not impactful otherwise. This may largely be due to the role of diffusive transport between cell populations (slowed in large macrogels vs. packed beds of microgels) and the localization of HSCs within a macrogel in prior studies versus in between hydrogel microgels in this study.

Cell encapsulation via droplet microfluidics is challenging. It subjects cells to shear stress that can decrease viability or alter cell behavior [78], and flow-focusing approaches with high throughput are an exception to the norm [42,79]. We have carried out significant efforts to encapsulate HSCs inside of microgels. In our hands, HSCs appear much more sensitive to the stresses of the microfluidic encapsulation process [41]. Proliferation is reduced and viability is lower for HSCs than for MSCs, which motivated the approaches we used here. Because MSCs appear to gradually migrate to the microgel surface over a period of 3–4 days, we expected that interstitial seeding would produce similar effects to MSC encapsulation while streamlining culture setup by eliminating cellular encapsulation within microgels. A surprising finding from this work was the disparate trajectories observed for HSCs as a function of direct vs. indirect interaction with MSCs; we have recently reported a multi-channel culture approach to study temporal changes in the morphology of individual (cancer) cells encapsulated in granular hydrogels [80]. Adapting this approach to study the close interactions of HSCs and MSCs within the granular culture system described here may offer new insight about strategies to improve the retention of HSCs already observed in this work. Nevertheless, the profound depletion of both LTHSCs and STHSCs when both HSCs and MSCs were interstitially seeded serves as motivation to encapsulate MSCs within microgels rather than simply seeding into a scaffold. Depletion of LTHSCs and STHSCs may have been caused by excessive Notch signaling. It has been shown that bone marrow MSCs express Delta-like ligand 1 [81]. Delaney et al. observed that low levels of immobilized Delta-like ligand 1 promoted the generation of human CD34+ HSPCs from cord blood in vitro, but a high density of this ligand was deleterious for HSPCs, suggesting a possible mechanism of action here [82]. It is possible that encapsulation of MSCs within microgels in this system is delaying an eventual loss in stemness which is immediately borne out when both cells are interstitially seeded. Alternatively, the relatively uninhibited proliferation of MSCs without a restrictive matrix may result in an imbalance in medium components that is deleterious for co-seeded HSCs. While this study shows that direct cell-cell signaling may have negatively contributed to stem cell maintenance, there is significant opportunity to leverage the flexibility of granular collections of microgels (with distinct cell populations within or between microgels) to explore this phenomenon in more detail.

Increases in the retention and proliferation of LSKs and LTHSCs would have a transformative impact on the practice of hematopoietic stem cell transplant, if realized. To facilitate expansion and recovery of human HSCs in a clinical setting, one may envision a system in which human HSCs could be encapsulated within tailored microgels, or perhaps more likely, supportive niche cells could be encapsulated within a packed bed of granular hydrogel that serves as an expansion scaffold. This approach uses gelatin, a physiologically relevant, but challenging and variable biomaterial, but this aspirational first step may seed the framework necessary to eventually accomplish a biomaterial-based HSC expansion platform.

This study represents a first-generation approach toward microgel-based HSC culture. The commonly cited advantages of microgels and granular approaches include enhanced scalability owing to reduced diffusive lengths, the capability to mix discretely tailored microgel populations, injectability, and porosity. Here, we showed the effects of reduced diffusive lengths on MSC activity by comparing microgel culture to macrogel culture. We observed large differences on the basis of gel morphology/encapsulation strategy, supporting the potency of this approach. Most notably, microgel-encapsulated MSCs provide a robust framework to create mosaic models of HSC-MSC crosstalk within the bone marrow and demonstrate promising increases in phenotypic LSKs and LTHSCs. The well-characterized nature of the murine hematopoietic system provides advantages regarding rigorous flow cytometric evaluation of hematopoietic progenitors removed from in vitro microgel cultures in this manuscript; it will be important in future extensions of this work using a smaller number of biomaterial culture conditions to perform in vivo evaluations (e.g., limiting dilution repopulation assays) to fully establish the functional importance of microgel culture.

5. Conclusions

We established an approach toward microgel-based, multicellular culture of HSCs with bone marrow-derived MSCs. We found that the encapsulation strategy – specifically, the choice to encapsulate within microgels as opposed within macrogels – can be a significant factor in the expression of physiologically relevant genes associated with matrix remodeling and maintenance of HSCs. We found that the mode of MSC seeding – encapsulated within microgels or interstitially in a bed of microgels – altered the maintenance of interstitially seeded HSCs in this model, motivating the pursuit of more challenging, but biologically crucial, encapsulation of MSCs within microgels for HSC support. The rich landscape of granular hydrogel design motifs presents a diverse array of future design approaches and modifications to tune this artificial bone marrow.

Supplementary Material

Supp Information

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.actbio.2026.06.009.

Acknowledgements

This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, Award Number 2 R01 DK099528. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors are also grateful for further funding provided by the Department of Chemical and Biomolecular Engineering and the Carl R. Woese Institute for Genomic Biology at the University of Illinois Urbana-Champaign. The authors would also like to thank the Functional Genomics Core and the Cytometry and Microscopy to Omics Cores within the Roy J. Carver Biotechnology Center at the University of Illinois Urbana-Champaign. Specifically, we would like to thank Tatsiana Akraiko for assistance with gene expression, and Dr. Marcin Wozniak for assistance with cell sorting. The authors used the CRediT (Contributor Roles Taxonomy) [83,84] framework to define their individual contributions to this manuscript.

Footnotes

CRediT authorship contribution statement

Gunnar B. Thompson: Writing – review & editing, Writing – original draft, Visualization, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Kaila M. Kuo: Methodology, Investigation. Andrés J. García: Writing – review & editing, Supervision. Brendan A.C. Harley: Writing – review & editing, Supervision, Resources, Project administration, Funding acquisition, Conceptualization.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Data availability statement

Data for this work is available upon reasonable request to the corresponding author.

References

  • [1].Jagannathan-Bogdan M, Zon LI, Hematopoiesis, Development 140 (12) (2013) 2463–2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL, Physiological migration of hematopoietic stem and progenitor cells, Science (1979) 294 (5548) (2001) 1933–1936. [DOI] [PubMed] [Google Scholar]
  • [3].D’Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S,Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM, Current use of and trends in hematopoietic cell transplantation in the United States, Biol. Blood Marrow TransPlant 26 (8) (2020) e177–e182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Barker JN, Boughan K, Dahi PB, Devlin SM, Maloy MA, Naputo K, Mazis CM, Davis E, Nhaissi M, Wells D, Cooper C, Ponce DM, Kernan N, Scaradavou A, Giralt SA, Papadopoulos EB, Politikos I, Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis, Blood Adv. 3 (7) (2019) 939–944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Martin PS, Li S, Nikiforow S, Alyea EP 3rd, Antin JH, Armand P, Cutler CS, Ho VT, Kekre N, Koreth J, Luckey CJ, Ritz J, Soiffer RJ, Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation, Haematologica 101 (4) (2016) 499–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Tӧrlen J, Ringden O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O’Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M, Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome, Biol. Blood Marrow TransPlant 20 (9) (2014) 1418–1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW,Devergie A, Esperou H, Thierry D, Socie G, Lehn P, et al. , Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling, N. Engl. J. Med. 321 (17) (1989) 1174–1178. [DOI] [PubMed] [Google Scholar]
  • [8].Ballen KK, Gluckman E, Broxmeyer HE, Umbilical cord blood transplantation: the first 25 years and beyond, Blood 122 (4) (2013) 491–498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Bastani S, Staal FJT, Canté-Barrett K, The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use, Stem Cell Investig. (2023) 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Pinho S, Frenette PS, Haematopoietic stem cell activity and interactions with the niche, Nat. Rev. Mol. Cell Biol. 20 (5) (2019) 303–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Morrison SJ, Scadden DT, The bone marrow niche for haematopoietic stem cells, Nature 505 (7483) (2014) 327–334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Chen X, Hughes R, Mullin N, Hawkins RJ, Holen I, Brown NJ, Hobbs JK, Mechanical heterogeneity in the bone microenvironment as characterized by atomic force microscopy, Biophys. J. 119 (3) (2020) 502–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Buxboim A, Rajagopal K, Brown AEX, Discher DE, How deeply cells feel: methods for thin gels, J. Phys.: Condens. Matter 22 (19) (2010) 194116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, Zaher W, Mortensen LJ, Alt C, Turcotte R, Yusuf R, Cote D, Vinogradov SA, Scadden DT, Lin CP, Direct measurement of local oxygen concentration in the bone marrow of live animals, Nature 508 (7495) (2014) 269–273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma’ayan A, Enikolopov GN, Frenette PS, Mesenchymal and haematopoietic stem cells form a unique bone marrow niche, Nature 466 (7308) (2010) 829–834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Ding L, Saunders TL, Enikolopov G, Morrison SJ, Endothelial and perivascular cells maintain haematopoietic stem cells, Nature 481 (7382) (2012) 457–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, Nagasawa T, The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche, Immunity 33 (3) (2010) 387–399. [DOI] [PubMed] [Google Scholar]
  • [18].Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS, Arteriolar niches maintain haematopoietic stem cell quiescence, Nature 502 (7473) (2013) 637–643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Kent D, Copley M, Benz C, Dykstra B, Bowie M, Eaves C, Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway, Clin. Cancer Res. 14 (7) (2008) 1926–1930. [DOI] [PubMed] [Google Scholar]
  • [20].Meaker GA, Wilkinson AC, Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions, Exp. Hematol. 130 (2024) 104136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Wilkinson AC, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo RV, Yamamoto R, Loh KM, Nakamura Y, Watanabe M, Nakauchi H, Yamazaki S, Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation, Nature 571 (7763) (2019) 117–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, Stuart JM, Gottgens B, Passegue E, Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions, Cell Stem Cell 17 (1) (2015) 35–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].McKenna HJ, Vries P.d., Brasel K, Lyman SD, Williams DE, Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells, Blood 86 (9) (1995) 3413–3420. [PubMed] [Google Scholar]
  • [24].Johnson CS, Williams M, Sham K, Belluschi S, Ma W, Wang X, Lau WWY, Kaufmann KB, Krivdova G, Calderbank EF, Mende N, McLeod J, Mantica G, Li J, Grey-Wilson C, Drakopoulos M, Basheer S, Sinha S, Diamanti E, Basford C, Wilson NK, Howe SJ, Dick JE, Göttgens B, Green AR, Francis N, Laurenti E, Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle, Blood 144 (7) (2024) 729–741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Pelagiadis I, Stiakaki E, Choulaki C, Kalmanti M, Dimitriou H, The role of children’s bone marrow mesenchymal stromal cells in the ex vivo expansion of autologous and allogeneic hematopoietic stem cells, Cell Biol. Int. 39 (10) (2015) 1099–1110. [DOI] [PubMed] [Google Scholar]
  • [26].Orticelli V, Papait A, Vertua E, Bonassi Signoroni P, Romele P, Di Pietro L, Magatti M, Teofili L, Silini AR, Parolini O, Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells, Stem Cells Transl. Med. 10 (11) (2021) 1516–1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Foroutan T, Farhadi A, Abroun S, Soltani BM, Adipose derived stem cells affect miR-145 and p53 expressions of co-cultured hematopoietic stem cells, Cell J. 19 (4) (2018) 654–659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Gilchrist AE, Harley BAC, Engineered Tissue Models to Replicate Dynamic Interactions within the Hematopoietic Stem Cell Niche, Adv. Healthcare Mater. 11 (7) (2022) e2102130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Rogkoti T, Donnelly H, Dalby MJ, Salmeron-Sanchez M, Mechanical signatures and models of the bone marrow niche, Natu. Rev. Bioeng. 3 (8) (2025) 697–713. [Google Scholar]
  • [30].Bello AB, Park H, Lee SH, Current approaches in biomaterial-based hematopoietic stem cell niches, Acta Biomater. 72 (2018) 1–15. [DOI] [PubMed] [Google Scholar]
  • [31].Kurth I, Franke K, Pompe T, Bornhauser M, Werner C, Hematopoietic stem and progenitor cells in adhesive microcavities, Integr. Biol. 1 (5–6) (2009) 427–434. [DOI] [PubMed] [Google Scholar]
  • [32].Roch A, Giger S, Girotra M, Campos V, Vannini N, Naveiras O, Gobaa S, Lutolf MP, Single-cell analyses identify bioengineered niches for enhanced maintenance of hematopoietic stem cells, Nat. Commun. 8 (1) (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Tavakol DN, Tratwal J, Bonini F, Genta M, Campos V, Burch P, Hoehnel S, Beduer A, Alessandrini M, Naveiras O, Braschler T, Injectable, scalable 3D tissue-engineered model of marrow hematopoiesis, Biomaterials 232 (2020) 119665. [DOI] [PubMed] [Google Scholar]
  • [34].Mousavi SH, Abroun S, Soleimani M, Mowla SJ, Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin, Int. J. Hematol. Oncol. Stem Cell Res. 9 (2) (2015) 72–79. [PMC free article] [PubMed] [Google Scholar]
  • [35].Gilchrist AE, Lee S, Hu Y, Harley BAC, Soluble signals and remodeling in a synthetic gelatin-based hematopoietic stem cell niche, Adv. Healthcare Mater. 8 (20) (2019) e1900751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Barnhouse V, Petrikas N, Crosby C, Zoldan J, Harley B, Perivascular secretome influences hematopoietic stem cell maintenance in a gelatin hydrogel, Ann. Biomed. Eng. 49 (2) (2021) 780–792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Richbourg NR, Wancura M, Gilchrist AE, Toubbeh S, Harley BAC, Cosgriff-Hernandez E, Peppas NA, Precise control of synthetic hydrogel network structure via linear, independent synthesis-swelling relationships, Sci. Adv. 7 (7) (2021) eabe3245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Gilchrist AE, Harley BAC, Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche, Integr. Biol. 12 (7) (2020) 175–187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Mahadik BP, Bharadwaj NA, Ewoldt RH, Harley BA, Regulating dynamic signaling between hematopoietic stem cells and niche cells via a hydrogel matrix, Biomaterials 125 (2017) 54–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Gilchrist AE, Serrano JF, Ngo MT, Hrnjak Z, Kim S, Harley BAC, Encapsulation of murine hematopoietic stem and progenitor cells in a thiolcrosslinked maleimide-functionalized gelatin hydrogel, Acta Biomater. (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Thompson GB, Gilchrist AE, Lam VM, Nunes AC, Payan BA, Mora-Boza A, Serrano JF, García AJ, Harley BAC, Gelatin maleimide microgels for hematopoietic progenitor cell encapsulation, J. Biomed. Mater. Res., Part A 112 (12) (2024) 2124–2135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Daly AC, Riley L, Segura T, Burdick JA, Hydrogel microparticles for biomedical applications, Nat. Rev. Mater. 5 (1) (2020) 20–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Thompson GB, Lee J, Kamani KM, Flores-Velasco N, Rogers SA, Harley BAC, Granular hydrogels as brittle yield stress fluids, Adv. Mater. 37 (39) (2025) e2503635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Wilkinson AC, Ishida R, Nakauchi H, Yamazaki S, Long-term ex vivo expansion of mouse hematopoietic stem cells, Nat. Protoc. 15 (2) (2020) 628–648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Headen DM, Aubry G, Lu H, Garcia AJ, Microfluidic-based generation of size-controlled, biofunctionalized synthetic polymer microgels for cell encapsulation, Adv. Mater. 26 (19) (2014) 3003–3008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Nilsson SK, Debatis ME, Dooner MS, Madri JA, Quesenberry PJ, Becker PS, Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ, J. Histochem. Cytochem. 46 (3) (1998) 371–377. [DOI] [PubMed] [Google Scholar]
  • [47].Klein G, Beck S, Müller CA, Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment, J. Cell Biol. 123 (4) (1993) 1027–1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Nakamura-Ishizu A, Okuno Y, Omatsu Y, Okabe K, Morimoto J, Uede T, Nagasawa T, Suda T, Kubota Y, Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration, Blood 119 (23) (2012) 5429–5437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Gu YC, Kortesmaa J, Tryggvason K, Persson J, Ekblom P, Jacobsen SE, Ekblom M, Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells, Blood 101 (3) (2003) 877–885. [DOI] [PubMed] [Google Scholar]
  • [50].Wong SW, Tamatam CR, Cho IS, Toth PT, Bargi R, Belvitch P, Lee JC, Rehman J, Reddy SP, Shin J-W, Inhibition of aberrant tissue remodelling by mesenchymal stromal cells singly coated with soft gels presenting defined chemomechanical cues, Nat. Biomed. Eng. 6 (1) (2022) 54–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Méndez-Ferrer S, Frenette PS, Hematopoietic stem cell trafficking: regulated adhesion and attraction to bone marrow microenvironment, Ann. NY Acad. Sci. 1116 (2007) 392–413. [DOI] [PubMed] [Google Scholar]
  • [52].Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods 25 (4) (2001) 402–408. [DOI] [PubMed] [Google Scholar]
  • [53].Ngo MT, Harley BAC, Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel, Biomaterials 198 (2019) 122–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Fukushima T, Tanaka Y, Hamey FK, Chang CH, Oki T, Asada S, Hayashi Y, Fujino T, Yonezawa T, Takeda R, Kawabata KC, Fukuyama T, Umemoto T, Takubo K, Takizawa H, Goyama S, Ishihama Y, Honda H, Gottgens B, Kitamura T, Discrimination of dormant and active hematopoietic stem cells by G0 marker reveals dormancy regulation by cytoplasmic calcium, Cell Rep. 29 (12) (2019) 4144–4158, e7. [DOI] [PubMed] [Google Scholar]
  • [55].Shapiro SS, Wilk MB, An analysis of variance test for normality (complete samples), Biometrika 52 (3/4) (1965) 591–611. [Google Scholar]
  • [56].Ghasemi A, Zahediasl S, Normality tests for statistical analysis: a guide for non-statisticians, Int. J. Endocrinol. Metab. 10 (2) (2012) 486–489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Brown MB, Forsythe AB, Robust tests for the equality of variances, J. Am. Stat. Assoc. 69 (346) (1974) 364–367. [Google Scholar]
  • [58].Carroll RJ, Schneider H, A note on levene’s tests for equality of variances, Stat. Probab. Lett. 3 (4) (1985) 191–194. [Google Scholar]
  • [59].Tukey JW, Comparing individual means in the analysis of variance, Biometrics 5 (2) (1949) 99–114. [PubMed] [Google Scholar]
  • [60].Welch BL, The generalization of `student’s’ problem when several different population variances are involved, Biometrika 34 (1/2) (1947) 28–35. [DOI] [PubMed] [Google Scholar]
  • [61].Kruskal WH, Wallis WA, Use of ranks in one-criterion variance analysis, J. Am. Stat. Assoc. 47 (260) (1952) 583–621. [Google Scholar]
  • [62].Wilcoxon F, Individual comparisons by ranking methods, Biometrics Bull. 1 (6) (1945) 80–83. [PubMed] [Google Scholar]
  • [63].Jansen LE, Birch NP, Schiffman JD, Crosby AJ, Peyton SR, Mechanics of intact bone marrow, J. Mech. Behav. Biomed. Mater. 50 (2015) 299–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Mora-Boza A, Ghebrezadik SG, Leisen JE, Garcia AJ, Rapid and facile light-based approach to fabricate protease-degradable poly(ethylene glycol)-norbornene microgels for cell encapsulation, Adv. Healthcare Mater. 12 (26) (2023) e2300942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [65].Sugiyama T, Kohara H, Noda M, Nagasawa T, Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches, Immunity. 25 (6) (2006) 977–988. [DOI] [PubMed] [Google Scholar]
  • [66].Ulyanova T, Scott LM, Priestley GV, Jiang Y, Nakamoto B, Koni PA,Papayannopoulou T, VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin, Blood 106 (1) (2005) 86–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Xu C, Gao X, Wei Q, Nakahara F, Zimmerman SE, Mar J, Frenette PS, Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow, Nat. Commun. 9 (1) (2018) 2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [68].Ding L, Morrison SJ, Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches, Nature 495 (7440) (2013) 231–235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Greenbaum A, Hsu Y-MS, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, Nagasawa T, Link DC, CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance, Nature 495 (7440) (2013) 227–230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Himburg HA, Termini CM, Schlussel L, Kan J, Li M, Zhao L, Fang T, Sasine JP, Chang VY, Chute JP, Distinct bone marrow sources of pleiotrophin control hematopoietic stem cell maintenance and regeneration, Cell Stem Cell 23 (3) (2018) 370–381, e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [71].Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN, Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells, Blood 106 (4) (2005) 1232–1239. [DOI] [PubMed] [Google Scholar]
  • [72].Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grünewald E, Cheng T, Dombkowski D, Calvi LM, Rittling SR, Scadden DT, Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size, J. Exp. Med. 201 (11) (2005) 1781–1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [73].Coutu DL, Kokkaliaris KD, Kunz L, Schroeder T, Three-dimensional map of nonhematopoietic bone and bone-marrow cells and molecules, Nat. Biotechnol. 35 (12) (2017) 1202–1210. [DOI] [PubMed] [Google Scholar]
  • [74].Choi JS, Harley BAC, Marrow-inspired matrix cues rapidly affect early fate decisions of hematopoietic stem and progenitor cells, Sci. Adv. 3 (1) (2017) e1600455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [75].Dao MA, Nolta JA, Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow, Blood 109 (6) (2006) 2373–2379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC, Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers, Tissue Eng., Part A 18 (7–8) (2012) 806–815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [77].Nishimura T, Hsu I, Martinez-Krams DC, Nakauchi Y, Majeti R, Yamazaki S, Nakauchi H, Wilkinson AC, Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion, Exp. Hematol. 80 (2019) 16–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Xu H-Q, Liu J-C, Zhang Z-Y, Xu C-X, A review on cell damage, viability, and functionality during 3D bioprinting, Mil. Med. Res. 9 (1) (2022) 70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Headen DM, García JR, García AJ, Parallel droplet microfluidics for high throughput cell encapsulation and synthetic microgel generation, Microsyst. Nanoeng. 4 (1) (2018). [Google Scholar]
  • [80].Payan BA, De Leon ACD, Anand T, Thompson GB, Krishnamurthy VV, Mora-Boza A, García AJ, Harley BAC, Hydrogel microdroplet based glioblastoma drug screening platform, J. Biomed. Mater. Res., Part A 114 (2) (2026) e70043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [81].Zhao X-L, Yang B, Ma L-N, Dong Y-H, MicroRNA-1 effectively induces differentiation of myocardial cells from mouse bone marrow mesenchymal stem cells, Artif. Cells Nanomed. Biotechnol. 44 (7) (2016) 1665–1670. [DOI] [PubMed] [Google Scholar]
  • [82].Delaney C, Varnum-Finney B, Aoyama K, Brashem-Stein C, Bernstein ID, Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells, Blood 106 (8) (2005) 2693–2699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [83].Brand A, Allen L, Altman M, Hlava M, Scott J, Beyond authorship: attribution, contribution, collaboration, and credit, 28, Learned Publishing, 2015, pp. 151–155. [Google Scholar]
  • [84].Allen L, Scott J, Brand A, Hlava M, Altman M, Publishing: credit where credit is due, Nature 508 (7496) (2014) 312–313. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp Information

Data Availability Statement

Data for this work is available upon reasonable request to the corresponding author.

RESOURCES